SAN FRANCISCO – Preparing for infectious disease outbreaks with potentially global impacts, both in the U.S. and abroad, must be a permanent and pivotal focus of the Centers for Disease Control and Prevention, CDC Director Dr. Robert Redfield said here in a conversation with IDSA President Dr. Paul Auwaerter and HIV Medicine Association Chair Dr. Melanie […]
The following is a guest post by Stephanie Mullen, DrPH, and Jim Thomas, PhD of MEASURE Evaluation USAID announced September 26 a new approach to fight tuberculosis: the Global Accelerator to End TB, a business model to treat 40 million people by 2022 through performance-based investments. One of USAID’s initial efforts on this front is […]
HIV
To control the global health threat of HIV by 2030, according to UNAIDS, these goals must be reached by 2020: To diagnose 90 percent of all […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With more than 112,000 cases of measles reported by 170 countries so far this year, the world is seeing rising rates of a vaccine-preventable illness over […]